Masimo Co. (NASDAQ:MASI) Director Adam Mikkelson sold 600 shares of the firm’s stock in a transaction dated Monday, January 10th. The shares were sold at an average price of $250.01, for a total value of $150,006.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
Masimo stock opened at $233.08 on Friday. The company’s fifty day simple moving average is $281.68 and its 200-day simple moving average is $276.08. Masimo Co. has a 12 month low of $205.10 and a 12 month high of $305.21. The stock has a market cap of $12.87 billion, a P/E ratio of 58.12 and a beta of 0.73.
Masimo (NASDAQ:MASI) last released its quarterly earnings data on Monday, October 25th. The medical equipment provider reported $0.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.91 by $0.03. Masimo had a net margin of 19.23% and a return on equity of 15.56%. The business had revenue of $307.40 million during the quarter, compared to analyst estimates of $295.79 million. During the same quarter in the previous year, the business earned $0.80 EPS. Masimo’s quarterly revenue was up 10.5% compared to the same quarter last year. On average, research analysts anticipate that Masimo Co. will post 3.88 earnings per share for the current year.
Several hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its stake in shares of Masimo by 9.4% in the 2nd quarter. BlackRock Inc. now owns 8,918,113 shares of the medical equipment provider’s stock valued at $2,162,196,000 after purchasing an additional 763,064 shares during the last quarter. Ownership Capital B.V. lifted its stake in shares of Masimo by 3.7% in the 3rd quarter. Ownership Capital B.V. now owns 2,010,906 shares of the medical equipment provider’s stock valued at $544,372,000 after purchasing an additional 71,861 shares during the last quarter. State Street Corp lifted its position in Masimo by 4.3% during the 2nd quarter. State Street Corp now owns 1,698,680 shares of the medical equipment provider’s stock worth $411,845,000 after acquiring an additional 69,274 shares during the last quarter. Invesco Ltd. lifted its position in Masimo by 0.7% during the 3rd quarter. Invesco Ltd. now owns 1,158,523 shares of the medical equipment provider’s stock worth $313,622,000 after acquiring an additional 8,613 shares during the last quarter. Finally, Champlain Investment Partners LLC lifted its position in Masimo by 14.6% during the 2nd quarter. Champlain Investment Partners LLC now owns 1,113,407 shares of the medical equipment provider’s stock worth $269,946,000 after acquiring an additional 141,445 shares during the last quarter. 82.76% of the stock is owned by institutional investors and hedge funds.
Masimo Company Profile
Masimo Corp. is a medical technology company, which develops, manufactures and markets non invasive patient monitoring technologies, medical devices and sensors. Its products include continuous monitors, patient-worn monitors, hospital automation connectivity, capnography & gas, data download & analytics and sensors & accessories.
Recommended Story: Margin
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.